Myrexis

Myrexis Current Ratio

The Current Ratio of Myrexis (MYRX) as of Oct 18, 2026 is 16.72. In the previous year, Current Ratio was 39.29 — a change of -57.46% (lower).

Current Ratio

16.72

YoY

-57.46%

Last updated:

Current Ratio of Myrexis is 2013 16.72 . Current Ratio of Myrexis was 2012 39.29 . It decreases by -57.46% lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Myrexis Stock analysis

What does Myrexis do? Myrexis Inc., based in New York City, operates in the Health Care sector with a focus on Biotechnology. The company evaluates strategic alternatives, including financial investments in life sciences assets, and previously developed drug candidates in oncology and autoimmune diseases. It suspended clinical development in 2012 and aims to build a commercial-stage biopharmaceutical company. Myrexis employs one full-time employee and conducts research and development activities primarily within the United States. Myrexis is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Myrexis stock

Current Ratio of Myrexis is 16.72 in 2013.

Current Ratio of Myrexis changed from 39.29 to 16.72, representing a -57.46% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Ratio Myrexis since 2006 – with annual values, charts, and detailed analysis.

The Current Ratio measures a company's ability to pay short-term obligations. A ratio above 1 indicates that current assets exceed current liabilities.

Current Ratio = Current Assets / Current Liabilities

A 'good' varies by industry and company stage. On Eulerpool, you can compare Current Ratio's Myrexis with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Myrexis

All Key Metrics — Myrexis